Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Hemodynamics and LBNP in Pre-hypertensive States
NCT01734096Phase 4Completed
- Start
- May 2009
- Primary completion
- Apr 2013
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of candesartan cilexetil in white coat hypertension (WCH) and obesity (4 arms). Primary endpoint: Sodium excretion. Started May 2009; status: completed.
02
Drugs
candesartan cilexetil
03
Conditions
white coat hypertension (WCH)obesity
Beyond the preview
Go deeper on NCT01734096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01734096.